Krishnaswamy Yeleswaram, Chief Development Officer: Rapport Therapeutics RAPP Sell · Filed 03/26

Trade details

Type: Insider sale
Amount: $303,348.85
Shares · price: 10,115 sh · $29.99 a share
Held after: 286,876 sh
Stock: Rapport Therapeutics RAPP
Person: Krishnaswamy YeleswaramChief Development Officer
Trade date: 26/03/25
Filed: 26/03/26
Days to filing: 1 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 02/23~04/24

Krishnaswamy Yeleswaram's recent trades

Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$1.8M
37,000 sh
$1.8M
Filed 08/25
Traded 08/25
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$553.4K
11,472 sh
$553.4K
Filed 08/24
Traded 08/24
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$102.5K
2,092 sh
$102.5K
Filed 08/19
Traded 08/19
Krishnaswamy YeleswaramChief Development Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$808.8K
20,225 sh
$808.8K
Filed 04/21
Traded 04/17
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$799.7K
20,225 sh
$799.7K
Filed 04/17
Traded 04/17